Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02038595 · ClinicalTrials.gov registry record · Early Phase 1
The Norepinephrine Transporter: A Novel Target for Imaging Brown Adipose Tissue
A Early Phase 1 study, sponsored by Yale University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 10
- Enrollment target
NCT02038595 is a Early Phase 1 study that has completed, run by Yale University. The registered enrollment target is 10 participants.
The verdict
NCT02038595, a Early Phase 1 study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 10 participants
- Enrollment target
Study Summary
This study seeks to assess a novel imaging technique to image brown adipose tissue utilizing the norepinephrine transporter.
Interventions
- RADIATION PET imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2012-09 |
| Est. Completion | 2013-12 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02038595
The ClinicalTrials.gov registry entry for NCT02038595 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PET imaging is the first listed.
NCT02038595 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02038595 about?
NCT02038595 is a clinical study titled "The Norepinephrine Transporter: A Novel Target for Imaging Brown Adipose Tissue". This study seeks to assess a novel imaging technique to image brown adipose tissue utilizing the norepinephrine transporter.
What is the current status of trial NCT02038595?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 10 participants. The study started on 2012-09. Estimated completion is 2013-12.
What interventions are being tested in trial NCT02038595?
The interventions under investigation include: PET imaging (RADIATION).
Who is sponsoring clinical trial NCT02038595?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.